Evaluation of direct and indirect effects of the PPARγ agonist troglitazone on mouse endothelial cell proliferation

Toxicologic Pathology

Volumn 39, Issue 7, 2011, Pages 1032-1045

  Kakiuchi Kiyota, Satoko ^a   Arnold, Lora L ^a   Yokohira, Masanao ^a   Koza Taylor, Petra ^b   Suzuki, Shugo ^c   Varney, Michelle ^a   Pennington, Karen L ^a   Cohen, Samuel M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

endothelial cell proliferation; hemangiosarcoma; hypoxia; oxidative stress; PPAR agonist; troglitazone

Indexed keywords

ALPHA TOCOPHEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SOMATOMEDIN C; TROGLITAZONE;

ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG CARCINOGENICITY; FEMALE; GENE EXPRESSION; HEMANGIOMA; HYPERLIPIDEMIA; HYPOXEMIA; LIVER; MITOGENICITY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR TUMOR; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CELL GROWTH PROCESSES; CELL HYPOXIA; CELL LINE; CHROMANS; DRINKING; ENDOTHELIAL CELLS; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HEMANGIOSARCOMA; HEPATOCYTES; HISTOCYTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; LIVER; MICE; ORGAN SIZE; OXIDATIVE STRESS; PPAR GAMMA; REPRODUCIBILITY OF RESULTS; THIAZOLIDINEDIONES; VITAMIN E;

EID: 82355169072     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311422080     Document Type: Article

References (57)

1. Alati T., Van Cleeff M., Jirtle R. L.. Radiosensitivity of parenchymal hepatocytes as a function of oxygen concentration. Radiat Res. 1989 ; 118: 488-501 (Pubitemid 19159480)
2. Aoki T.. Current status of carcinogenicity assessment of peroxisome proliferator-activated receptor agonists by the US FDA and a mode-of-action approach to the carcinogenic potential. J Toxicol Pathol. 2007 ; 20: 197-202
3. Arteel G. E., Thurman R. G., Yates J. M., Raleigh J. A.. Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver. Br J Cancer. 1995 ; 72: 889-95
4. Bar R. S., Dolash S., Dake B. L., Boes M.. Cultured capillary endothelial cells from bovine adipose tissue: A model for insulin binding and action in microvascular endothelium. Metabolism. 1986 ; 35: 317-22 (Pubitemid 16079522)
5. Bull A. W., Nigro N. D., Golembieski W. A., Crissman J. D., Marnett L. J.. In vivo stimulation of DNA synthesis and induction of ornithine decarboxylase in rat colon by fatty acid hydroperoxides, autoxidation products of unsaturated fatty acids. Cancer Res. 1984 ; 44: 4924-28 (Pubitemid 15204442)
6. Bull A. W., Nigro N. D., Marnett L. J.. Structural requirements for stimulation of colonic cell proliferation by oxidized fatty acids. Cancer Res. 1988 ; 48: 1771-76
7. Cheong S. M., Choi S. C., Han J. K.. Xenopus Dab2 is required for embryonic angiogenesis. BMC Dev Biol. 2006 ; 6: 63
8. Chow C. K., Ibrahim W., Wei Z., Chan A. C.. Vitamin E regulates mitochondrial hydrogen peroxide generation. Free Radic Biol Med. 1999 ; 27: 580-87 (Pubitemid 29408644)
9. Cohen S. M., Ellwein L. B.. Cell proliferation in carcinogenesis. Science. 1990 ; 249: 1007-11
10. Cohen S. M., Ellwein L. B.. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 1991 ; 51: 6493-505
11. Cohen S. M., Storer R. D., Criswell K. A., Doerrer N. G., Dellarco V. L., Pegg D. G., Wojcinski Z. W., Malarkey D. E., Jacobs A. C., Klaunig J. E., Swenberg J. A., Cook J. C.. Hemangiosarcoma in rodents: Mode-of-action evaluation and human relevance. Toxicol Sci. 2009 ; 111: 4-18
12. Copple B. L., Bustamante J. J., Welch T. P., Kim N. D., Moon J. O.. Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes. Liver Int. 2009 ; 29: 1010-21
13. Corthals S. M., Kamendulis L. M., Klaunig J. E.. Mechanisms of 2-butoxyethanol-induced hemangiosarcomas. Toxicol Sci. 2006 ; 92: 378-86 (Pubitemid 44018954)
14. Duddy S. K., Parker R. F., Bleavins M. R., Gough A. W., Rowse P. E., Gorospe S., Dethloff L. A., de la Iglesia F. A.. p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone. Toxicol Appl Pharmacol. 1999 ; 156: 106-12 (Pubitemid 29196573)
15. Elson D. A., Thurston G., Huang L. E., Ginzinger D. G., McDonald D. M., Johnson R. S., Arbeit J. M.. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 2001 ; 15: 2520-32 (Pubitemid 32937863)
16. Hardisty J. F., Elwell M. R., Ernst H., Greaves P., Kolenda-Roberts H., Malarkey D. E., Mann P. C., Tellier P. A.. Histopathology of hemangiosarcomas in mice and hamsters and liposarcomas/fibrosarcomas in rats associated with PPAR agonists. Toxicol Pathol. 2007 ; 35: 928-41
17. Hellstrom A., Perruzzi C., Ju M., Engstrom E., Hard A. L., Liu J. L., Albertsson-Wikland K., Carlsson B., Niklasson A., Sjodell L., LeRoith D., Senger D. R., Smith L. E.. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001 ; 98: 5804-8 (Pubitemid 32435723)
18. Herman J. R., Dethloff L. A., McGuire E. J., Parker R. F., Walsh K. M., Gough A. W., Masuda H., de la Iglesia F. A.. Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazone. Toxicol Sci. 2002 ; 68: 226-36 (Pubitemid 34785244)
19. Humar R., Kiefer F. N., Berns H., Resink T. J., Battegay E. J.. Hypoxia enhances vascular cell proliferation and angiogenesis in vivo via rapamycin (mTOR)-dependent signaling. FASEB J. 2002 ; 16: 771-80 (Pubitemid 34615125)
20. Ibrahim W., Lee U. S., Yeh C. C., Szabo J., Bruckner G., Chow C. K.. Oxidative stress and antioxidant status in mouse liver: Effects of dietary lipid, vitamin E and iron. J Nutr. 1997 ; 127: 1401-6 (Pubitemid 27284011)
21. Iivanainen E., Paatero I., Heikkinen S. M., Junttila T. T., Cao R., Klint P., Jaakkola P. M., Cao Y., Elenius K.. Intra- and extracellular signaling by endothelial neuregulin-1. Exp Cell Res. 2007 ; 313: 2896-909 (Pubitemid 47126431)
22. Irwin D. C., McCord J. M., Nozik-Grayck E., Beckly G., Foreman B., Sullivan T., White M. T., Crossno J J., Bailey D., Flores S. C., Majka S., Klemm D., van Patot M. C.. A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. Free Radic Biol Med. 2009 ; 47: 55-61
23. Iyer N. V., Kotch L. E., Agani F., Leung S. W., Laughner E., Wenger R. H., Gassmann M., Gearhart J. D., Lawler A. M., Yu A. Y., Semenza G. L.. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998 ; 12: 149-62 (Pubitemid 28060446)
24. Jat P. S., Noble M. D., Ataliotis P., Tanaka Y., Yannoutsos N., Larsen L., Kioussis D.. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A. 1991 ; 88: 5096-100 (Pubitemid 21914690)
25. Ji S., Lemasters J. J., Christenson V., Thurman R. G.. Periportal and pericentral pyridine nucleotide fluorescence from the surface of the perfused liver: Evaluation of the hypothesis that chronic treatment with ethanol produces pericentral hypoxia. Proc Natl Acad Sci U S A. 1982 ; 79: 5415-19 (Pubitemid 13233749)
26. Kakiuchi-Kiyota S., Vetro J. A., Suzuki S., Varney M. L., Han H. Y., Nascimento M., Pennington K. L., Arnold L. L., Singh R. K., Cohen S. M.. Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vivo: Differences between human and mouse. Toxicol Appl Pharmacol. 2009 ; 237: 83-90
27. Katoh S., Hata S., Matsushima M., Ikemoto S., Inoue Y., Yokoyama J., Tajima N.. Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy-a randomized controlled trial. Metabolism. 2001 ; 50: 414-17 (Pubitemid 32321949)
28. Kawai T., Takei I., Oguma Y., Ohashi N., Tokui M., Oguchi S., Katsukawa F., Hirose H., Shimada A., Watanabe K., Saruta T.. Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes. Metabolism. 1999 ; 48: 1102-7 (Pubitemid 29418278)
29. Kermani P., Hempstead B.. Brain-derived neurotrophic factor: A newly described mediator of angiogenesis. Trends Cardiovasc Med. 2007 ; 17: 140-43 (Pubitemid 46670025)
30. King G. L., Goodman A. D., Buzney S., Moses A., Kahn C. R.. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest. 1985 ; 75: 1028-36 (Pubitemid 15115273)
31. Klaunig J. E., Kamendulis L. M.. Mode of action of butoxyethanol-induced mouse liver hemangiosarcomas and hepatocellular carcinomas. Toxicol Lett. 2005 ; 156: 107-15 (Pubitemid 40227416)
32. Knight T. R., Fariss M. W., Farhood A., Jaeschke H.. Role of lipid peroxidation as a mechanism of liver injury after acetaminophen overdose in mice. Toxicol Sci. 2003 ; 76: 229-36 (Pubitemid 37361902)
33. Kondo T., Vicent D., Suzuma K., Yanagisawa M., King G. L., Holzenberger M., Kahn C. R.. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest. 2003 ; 111: 1835-42 (Pubitemid 38057728)
34. Laifenfeld D., Gilchrist A., Drubin D., Jorge M., Eddy S. F., Frushour B. P., Ladd B., Obert L. A., Gosink M. M., Cook J. C., Criswell K., Somps C. J., Koza-Taylor P., Elliston K. O., Lawton M. P.. The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma. Toxicol Sci. 2009 ; 113: 254-66
35. Langley R. R., Ramirez K. M., Tsan R. Z., Van Arsdall M., Nilsson M. B., Fidler I. J.. Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res. 2003 ; 63: 2971-76 (Pubitemid 36667171)
36. Lien E. L., Boyle F. G., Wrenn J. M., Perry R. W., Thompson C. A., Borzelleca J. F.. Comparison of AIN-76A and AIN-93G diets: A 13-week study in rats. Food Chem Toxicol. 2001 ; 39: 385-92 (Pubitemid 32280819)
37. Ma Q. L., Yang T. L., Yin J. Y., Peng Z. Y., Yu M., Liu Z. Q., Chen F. P.. Role of insulin-like growth factor-1 (IGF-1) in regulating cell cycle progression. Biochem Biophys Res Commun. 2009 ; 389: 150-55
38. Martin R. A., Daly A., DiFonzo C. J., de la Iglesia F. A.. Randomization of animals by computer program for toxicity studies. J Environ Pathol Toxicol Oncol. 1986 ; 6: 143-52 (Pubitemid 17224804)
39. Martindale J. L., Holbrook N. J.. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol. 2002 ; 192: 1-15 (Pubitemid 34587382)
40. Medinsky M. A., Popp J. A., Hamm T. E., Dent J. G.. Development of hepatic lesions in male Fischer-344 rats fed AIN-76A purified diet. Toxicol Appl Pharmacol. 1982 ; 62: 111-20 (Pubitemid 12219115)
41. Morani A., Barros R. P., Imamov O., Hultenby K., Arner A., Warner M., Gustafsson J. A.. Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice. Proc Natl Acad Sci U S A. 2006 ; 103: 7165-69
42. Mori Y., Murakawa Y., Okada K., Horikoshi H., Yokoyama J., Tajima N., Ikeda Y.. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care. 1999 ; 22: 908-12 (Pubitemid 29241043)
43. Narayanan P. K., Hart T., Elcock F., Zhang C., Hahn L., McFarland D., Schwartz L., Morgan D. G., Bugelski P.. Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: A flow cytometric assessment. Cytometry A. 2003 ; 52: 28-35 (Pubitemid 37522531)
44. Pollak M. N., Schernhammer E. S., Hankinson S. E.. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004 ; 4: 505-18 (Pubitemid 38868620)
45. Pugh C. W., Ratcliffe P. J.. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med. 2003 ; 9: 677-84 (Pubitemid 36749216)
46. Rosai J., Sobin L. H. Atlas of Tumor Pathology. Washington, D.C.: Armed Forces Institute of Pathology ; 1998 :
47. Samoszuk M. K., Walter J., Mechetner E.. Improved immunohistochemical method for detecting hypoxia gradients in mouse tissues and tumors. J Histochem Cytochem. 2004 ; 52: 837-39 (Pubitemid 38703139)
48. Siesky A. M., Kamendulis L. M., Klaunig J. E.. Hepatic effects of 2-butoxyethanol in rodents. Toxicol Sci. 2002 ; 70: 252-60 (Pubitemid 36013658)
49. Simpson M. A.. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Am J Pathol. 2006 ; 169: 247-57
50. Stone J. R., Collins T.. The role of hydrogen peroxide in endothelial proliferative responses. Endothelium. 2002 ; 9: 231-38 (Pubitemid 36040395)
51. Sun C. Y., Hu Y., Wang H. F., He W. J., Wang Y. D., Wu T.. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases. Chin Med J (Engl). 2006 ; 119: 589-95 (Pubitemid 43796865)
52. Tafazoli S., Wright J. S., OBrien P. J.. Prooxidant and antioxidant activity of vitamin E analogues and troglitazone. Chem Res Toxicol. 2005 ; 18: 1567-74 (Pubitemid 41504477)
53. Tentori L., Lacal P. M., Muzi A., Dorio A. S., Leonetti C., Scarsella M., Ruffini F., Xu W., Min W., Stoppacciaro A., Colarossi C., Wang Z. Q., Zhang J., Graziani G.. Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis. Eur J Cancer. 2007 ; 43: 2124-33 (Pubitemid 47380363)
54. Van Os-Corby D. J., Koch C. J., Chapman J. D.. Is misonidazole binding to mouse tissues a measure of cellular pO2?. Biochem Pharmacol. 1987 ; 36: 3487-94 (Pubitemid 18012224)
55. Varia M. A., Calkins-Adams D. P., Rinker L. H., Kennedy A. S., Novotny D. B., Fowler W. C., Raleigh J. A.. Pimonidazole: A novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol. 1998 ; 71: 270-77 (Pubitemid 28550812)
56. Yamakawa M., Liu L. X., Date T., Belanger A. J., Vincent K. A., Akita G. Y., Kuriyama T., Cheng S. H., Gregory R. J., Jiang C.. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res. 2003 ; 93: 664-73 (Pubitemid 37222163)
57. Zhao F., Xuan Z., Liu L., Zhang M. Q.. TRED: A Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies. Nucleic Acids Res. 2005 ; 33: D103-7